Bizarre re SRDX: http://finance.yahoo.com/news/SurModics-Announces-bw-3241134625.html?x=0 The Company has postponed its previously scheduled conference call this afternoon, and will announce the rescheduled date and time as soon as practical following the completion of the reevaluation of the accounting treatment for the fourth quarter Pharmaceuticals asset impairment charge. Why would such a technical matter as the accounting treatment of an asset sale have to delay a quarterly CC?